Jonathan Biller
Treasurer chez JUNO THERAPEUTICS INC
Fortune : 8 M $ au 31/03/2024
Profil
Jonathan Prim Biller is currently a Director at Acetylon Pharmaceuticals, Inc., Celgene UK Manufacturing (II) Ltd., Celgene UK Manufacturing Ltd., Celgene UK Holdings Ltd., and Celgene Europe Ltd.
He is also the Chief Legal Officer & Executive Vice President at Vertex Pharmaceuticals, Inc. and the Treasurer at Juno Therapeutics, Inc. Previously, he worked as a Director at Junior Achievement of New Jersey, Inc., Celgene Ltd., and Foley & Lardner LLP.
He served as the Executive Vice President & General Counsel at Celgene Corp.
and as the Secretary, Chief Tax Officer & General Counsel at Bunge Ltd.
He was also the CFO, Head-Legal & Corporate Affairs at Agios Pharmaceuticals, Inc. and a Partner at Hopkins & Sutter.
Mr. Biller received his undergraduate degree from Brown University in 1985 and his graduate degree from Yale Law School in 1989.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 12/02/2024 | 18 280 ( 0,01% ) | 8 M $ | 31/03/2024 | |
| 31/03/2023 | 9 643 ( 0,02% ) | 281 961 $ | 31/03/2024 |
Postes actifs de Jonathan Biller
| Sociétés | Poste | Début |
|---|---|---|
| JUNO THERAPEUTICS INC | Treasurer | - |
| VERTEX PHARMACEUTICALS INCORPORATED | General Counsel | 19/09/2022 |
Celgene Europe Ltd.
 Celgene Europe Ltd. BiotechnologyHealth Technology Part of Bristol Myers Squibb Co., Celgene Europe Ltd. is a British company that engages in research and development in pharmaceutical products. The private company is based in Middlesex, UK. | Director/Board Member | - |
Celgene UK Holdings Ltd.
 Celgene UK Holdings Ltd. Financial ConglomeratesFinance Part of Bristol Myers Squibb Co., Celgene UK Holdings Ltd. functions as an investment holding private company. The company is based in London, UK. | Director/Board Member | - |
Celgene UK Manufacturing (II) Ltd.
 Celgene UK Manufacturing (II) Ltd. Financial ConglomeratesFinance Part of Bristol Myers Squibb Co., Celgene UK Manufacturing (II) Ltd. functions as an investment holding private company. The company is based in London, UK. | Director/Board Member | - |
Celgene UK Manufacturing Ltd.
 Celgene UK Manufacturing Ltd. Financial ConglomeratesFinance Part of Bristol Myers Squibb Co., Celgene UK Manufacturing Ltd. functions as an investment holding private company. The company is based in London, UK. | Director/Board Member | - |
Acetylon Pharmaceuticals, Inc.
 Acetylon Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Acetylon Pharmaceuticals, Inc. develops pharmaceutical technology. It develops novel small molecule drugs which targets epigenetic mechanisms for the enhancement of therapeutic outcomes in cancer and other critical human diseases. The company was founded by Ralph Mazitschek, Kenneth C. Anderson, Marc A. Cohen, James E. Bradner, and Walter C. Ogier in October 2008 and is headquartered in Boston, MA. | Director/Board Member | - |
Anciens postes connus de Jonathan Biller
| Sociétés | Poste | Fin |
|---|---|---|
| AGIOS PHARMACEUTICALS, INC. | Director of Finance/CFO | 16/09/2022 |
| CELGENE | Comptroller/Controller/Auditor | 03/07/2018 |
| ░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
| ░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░ ░░░░░ ░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - |
Formation de Jonathan Biller
| Brown University | Undergraduate Degree |
| Yale Law School | Graduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| VERTEX PHARMACEUTICALS INCORPORATED | Health Technology |
| AGIOS PHARMACEUTICALS, INC. | Health Technology |
| Entreprise privées | 12 |
|---|---|
Celgene Corp.
 Celgene Corp. BiotechnologyHealth Technology Celgene Corp. is an integrated global biopharmaceutical company, which engages in the discovery, development and commercialization of therapies for the treatment of cancer and inflammatory diseases. Its primary commercial stage products include Revlimid, Pomalyst, Imnovid, Otezla, Abraxane, and Vidaza. The company was founded by David Stirling and Sol Barer in 1986 and is headquartered in Summit, NJ. | Health Technology |
Foley & Lardner LLP
 Foley & Lardner LLP Miscellaneous Commercial ServicesCommercial Services Foley & Lardner LLP engages in the provision of legal services. Its practice areas include employee benefits and executive compensation, environmental, estates and trusts, finance, international tax and transfer pricing, private equity and venture capital, real estate, securities, commodities and exchange regulation, taxation, and transactions. The company was founded by Asahel Finch and William Pitt Lynde on September 8, 1842 and is headquartered in Milwaukee, WI. | Commercial Services |
Bunge Ltd.
 Bunge Ltd. Agricultural Commodities/MillingProcess Industries Bunge Global SA operates as a holding company. engages in the supply and transportation of agricultural commodities. It operates through the following segments: Agribusiness, Refined and Specialty Oils, Milling, and Sugar and Bioenergy. The Agribusiness segment is involved in the purchase, storage, transportation, processing, and sale of agricultural commodities and commodity products. The Refined and Specialty Oils segment engages in the processing, production, and marketing of products derived from vegetable oils. The Milling segment consists of the processing, production, and marketing of products derived primarily from wheat and corn. The Sugar and Bioenergy segment includes the manufacture and marketing of sugar and ethanol derived from sugarcane, as well as energy derived from the sugar and ethanol production process. The company was founded by Johann Peter Gottlieb Bunge in 1818 and is headquartered in St. Louis, MO. | Process Industries |
| Hopkins & Sutter | Commercial Services |
| Junior Achievement of New Jersey, Inc. | |
Acetylon Pharmaceuticals, Inc.
Acetylon Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Acetylon Pharmaceuticals, Inc. develops pharmaceutical technology. It develops novel small molecule drugs which targets epigenetic mechanisms for the enhancement of therapeutic outcomes in cancer and other critical human diseases. The company was founded by Ralph Mazitschek, Kenneth C. Anderson, Marc A. Cohen, James E. Bradner, and Walter C. Ogier in October 2008 and is headquartered in Boston, MA. | Health Technology |
Celgene UK Manufacturing Ltd.
Celgene UK Manufacturing Ltd. Financial ConglomeratesFinance Part of Bristol Myers Squibb Co., Celgene UK Manufacturing Ltd. functions as an investment holding private company. The company is based in London, UK. | Finance |
Celgene UK Holdings Ltd.
Celgene UK Holdings Ltd. Financial ConglomeratesFinance Part of Bristol Myers Squibb Co., Celgene UK Holdings Ltd. functions as an investment holding private company. The company is based in London, UK. | Finance |
Juno Therapeutics, Inc.
 Juno Therapeutics, Inc. BiotechnologyHealth Technology Juno Therapeutics, Inc. is a biopharmaceutical company, which engages in the development of innovative cellular immunotherapy for the treatment of cancer. It offers platforms which includes chimeric antigen receptors and T-cell receptors. The company was founded by Hans Edgar Bishop, Lawrence Corey, Richard D. Klausner, Stan Riddell, Isabelle Riviere, and Robert Taylor Nelsen on August 5, 2013 and is headquartered in Seattle, WA. | Health Technology |
Celgene Ltd.
 Celgene Ltd. Pharmaceuticals: MajorHealth Technology Celgene Ltd. engages in the development of human pharmaceuticals and agrochemicals. It focuses on the discovery, the development, and the commercialization of products for the treatment of cancer and other severe, immune, inflammatory conditions. The company was founded on June 2, 2015 and is headquartered in Uxbridge, the United Kingdom. | Health Technology |
Celgene Europe Ltd.
Celgene Europe Ltd. BiotechnologyHealth Technology Part of Bristol Myers Squibb Co., Celgene Europe Ltd. is a British company that engages in research and development in pharmaceutical products. The private company is based in Middlesex, UK. | Health Technology |
Celgene UK Manufacturing (II) Ltd.
Celgene UK Manufacturing (II) Ltd. Financial ConglomeratesFinance Part of Bristol Myers Squibb Co., Celgene UK Manufacturing (II) Ltd. functions as an investment holding private company. The company is based in London, UK. | Finance |
